H Kropp
Impact in
- Molecular Medicine top 0.2%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
- Pharmacology 17
- Antibiotics Pharmacokinetics and Efficacy 16
-
- Antibiotic Resistance in Bacteria 14
- Co-authors
- Frederick M. Kahan (10 shared papers)Jon G. Sundelof (10 shared papers)Jean S. Kahan (4 shared papers)Patrick J. Cassidy (1 shared paper)Jerome Birnbaum (3 shared papers)Richard Hajdu (5 shared papers)J. J. Jackson (2 shared papers)J. S. Macdonald (1 shared paper)
- Journals
- Antimicrobial Agents and Chemotherapy (14 papers)Journal of Medicinal Chemistry (2 papers)The Journal of Infectious Diseases (2 papers)The Journal of Antibiotics (1 paper)Clinical Infectious Diseases (1 paper)
- Partner nations
- United StatesSwedenJapan
In The Last Decade
H Kropp
34 papers receiving 2.6k citations
H Kropp's Hit Papers
Peers
Comparison fields: 5 of 112
- Molecular Medicine 1.0k
- Applied Microbiology and Biotechnology 175
- Pharmacology 1.2k
- Infectious Diseases 713
- Clinical Biochemistry 171
Countries citing papers authored by H Kropp
This map shows the geographic impact of H Kropp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Kropp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Kropp more than expected).
Fields of papers citing papers by H Kropp
This network shows the impact of papers produced by H Kropp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Kropp. The network helps show where H Kropp may publish in the future.
Co-authors
The 25 scholars most cited alongside H Kropp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | THE MECHANISM OF ACTION OF FOSFOMYCIN (PHOSPHONOMYCIN) Hit paper breakdown → | 1974 | 636 |
| 2 | 1982 | 282 | |
| 3 | 1983 | 258 | |
| 4 | 1985 | 216 | |
| 5 | 1997 | 204 | |
| 6 | 1980 | 162 | |
| 7 | 1992 | 152 | |
| 8 | 1997 | 141 | |
| 9 | 1983 | 132 | |
| 10 | 1985 | 106 | |
| 11 | 1995 | 67 | |
| 12 | 1999 | 67 | |
| 13 | 1973 | 61 | |
| 14 | 1998 | 57 | |
| 15 | 1992 | 55 | |
| 16 | 1995 | 47 | |
| 17 | 1996 | 45 | |
| 18 | 1972 | 35 | |
| 19 | 1997 | 31 | |
| 20 | 1999 | 17 |
About H Kropp
H Kropp is a scholar working on Pharmacology, Molecular Medicine, Infectious Diseases, Oncology and Epidemiology, having authored 35 papers that have together received 2.9k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (16 papers), Antibiotic Resistance in Bacteria (14 papers), Antimicrobial Resistance in Staphylococcus (5 papers), Antifungal resistance and susceptibility (5 papers), Pneumocystis jirovecii pneumonia detection and treatment (3 papers), Phenothiazines and Benzothiazines Synthesis and Activities (2 papers), Veterinary medicine and infectious diseases (2 papers) and Helicobacter pylori-related gastroenterology studies (2 papers). The work is most often cited by research in Molecular Medicine (1.0k citations), Applied Microbiology and Biotechnology (175 citations), Pharmacology (1.2k citations), Infectious Diseases (713 citations) and Clinical Biochemistry (171 citations). H Kropp has collaborated with scholars based in United States, Sweden and Japan. Frequent co-authors include Frederick M. Kahan, Jon G. Sundelof, Jean S. Kahan, Patrick J. Cassidy, Jerome Birnbaum, Richard Hajdu, J. J. Jackson, J. S. Macdonald, George K. Abruzzo and Ken Bartizal. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Medicinal Chemistry, The Journal of Infectious Diseases, The Journal of Antibiotics and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.